Category: Include on Menu
-
Gold Prices Ease as Stronger Dollar Limits Demand Ahead of Federal Reserve Decision
Gold prices moved lower on Tuesday as the US dollar remained close to its highest level in nearly a month, while investors adopted a cautious approach ahead of the Federal Reserve’s interest rate announcement and comments from Chair Kevin Warsh. Spot gold declined 0.7% to $4,048.40 per ounce by 07:07 GMT, while US Gold Futures…
-
US Markets Await Key Earnings and Federal Reserve Decision as AI Spending Faces Fresh Scrutiny: Dow Jones, S&P, Nasdaq, Wall Street Futures
US equity futures traded without a clear direction on Tuesday as investors prepared for a pivotal week of corporate earnings, while attention also turned to the Federal Reserve’s policy meeting and ongoing geopolitical developments in the Middle East. By 07:43 GMT, Dow Jones futures were up 41 points, or 0.1%, while S&P 500 futures slipped…
-
Delta Gold Technologies Looks Beyond Conventional Quantum Computing With a Distinctive Research Strategy
As investment pours into quantum computing, much of the industry’s attention has centred on making today’s technologies bigger and faster. Delta Gold Technologies(USOTC:DGQTF)(AQSE:DGQ)(FRA:02J) is taking a different route. During a recent fireside discussion, CEO and Co-founder Mike Jones was joined by Professor Harry Ruda from the University of Toronto and Professor Ken Knappenberger from Penn…
-
Dow Climbs as Middle East Calm Sinks Oil, While an Nvidia-Led Tech Slide Caps the Nasdaq
U.S. stocks finished mixed on Monday as an easing of Middle East tensions sent oil prices tumbling and lifted much of the broader market, even as renewed worries about heavy spending on artificial intelligence dragged technology shares lower. The split left blue-chip stocks higher and the tech-heavy Nasdaq slightly in the red, a familiar tug-of-war…
-
Vivos Reports FDA IDE Approval and Expands Precision Radionuclide Therapy Programs
Vivos (USOTC:RDGL) reported second-quarter 2026 progress across its Precision Radionuclide Therapy™ programs, highlighting FDA approval to begin its first U.S. human clinical study, continued advancement of international trials, and growth in its veterinary cancer treatment business. Key Investor Takeaways Why RDGL Stock Is In Focus Vivos announced several operational and regulatory milestones centered on its…
-
American Fusion Presents Texatron Fusion Technology at APS Particle Physics Conference
American Fusion (USOTC:AMFN) announced that Chief Technology Officer Dr. John Brandenburg presented the company’s Texatron™ Fusion Engine™ technology and Gravity-Electromagnetic (GEM) Unification Theory at the 2026 American Physical Society Division of Particles and Fields meeting held at Fermilab. Key Investor Takeaways Why AMFN Stock Is In Focus American Fusion announced that Chief Technology Officer Dr.…
-
Black Dragon Resource Companies Advances Frac Sand Project Toward Commercial Operations
Black Dragon Resource Companies (USOTC:BDGR) said it is progressing toward commercial operations as it evaluates the purchase of a sand processing plant, advances its contracted frac sand property, and continues pursuing additional growth initiatives. Key Investor Takeaways Why BDGR Stock Is In Focus Black Dragon Resource Companies provided an operational update outlining progress on its…
-
Vivakor Advances Houston Remediation Processing Center Toward Commercial Operations
Vivakor (NASDAQ:VIVK) has started commissioning its Houston Remediation Processing Center after capital funding commitments under its Monarch joint venture were fulfilled, marking another step toward bringing the facility into commercial operation. Key Investor Takeaways Why VIVK Stock Is In Focus Vivakor announced that the capital funding commitments contemplated under its previously announced Monarch Remediation &…
-
Virtuix Sells First Omni One Enterprise System to Tesla’s Optimus Robot Division
Virtuix (NASDAQ:VTIX) announced the sale of its first Omni One Enterprise system to Tesla’s Optimus humanoid robot division, expanding the company’s presence in enterprise robotics and simulation applications. Key Investor Takeaways Why VTIX Stock Is In Focus Virtuix announced that Tesla has purchased its first Omni One Enterprise system for use by the company’s Optimus…
-
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
Profusa (NASDAQ:PFSA) has signed a non-binding term sheet to acquire a commercial-stage diagnostics company with estimated 2025 net revenue of approximately $111 million, while also reshaping its executive leadership as it pivots toward a diagnostics-focused business model. Key Investor Takeaways Why PFSA Stock Is In Focus Profusa announced it has entered into a non-binding term…